Nephropathie, Klinik und Prävention

Literatur

• 1 Persson P B, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephrophathy.  Kidney Int. 2005;  68 14-22
• 2 Merten G J, Burgess W P, Gray L V. et al . Prevention of contrast-induced nephrophathy with sodium bicarbonat.  JAMA. 2004;  291 2328-2334
• 3 Aspelin P, Aubry P, Fransson S -G, Strasser R, Willenbrock R, Berg K J. Nephrotoxic effects in high-risk patients undergoing angiography.  N Engl J Med. 2003;  348 491-499
• 4 Baker C SR, Wragg A, Jumar S, De Palma R, Baker L RI, Knight C J. A Rapid Protocol for the prevention of Contrast-Induced Renal Dysfunction. The RAPPID study.  J Am Coll Cardiol. 2003;  41 2114-2118
• 5 Stone G W, McCullough P A, Tumlin J A. et al . Fenoldopam Mesylate for the Prevention of Contrast-induced Nephropathy. A Randomized Controlled Trial.  JAMA. 2003;  290 2284-2291
• 6 Liss P, Persson P, Hansell P, Nilsson T, Lagerkvist B. Two-fold Higher Incidence of Renal Failure in 52,526 Patients Undergoing Coronary Interventions of Swedish Hospitals Using Iso-osmolar Contrast Media Compared to Low-osmolar Contrast Media.  RSNA. 2005;  , http://rsna2005.rsma.org/rsna2005/conference/event_display.cfm?em_id = 4 415 382
• 7 Adolph E. et al . Kontrastmittel-induzierte Nephropathie. Klinik und Prävention.  Dtsch Med Wochenschr. 2005;  130 2391-2396